- Home
- KAR vs HRMY Comparison
KAR vs HRMY Comparison
Compare KAR & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KAR
- HRMY
- Stock Information
- Founded
- KAR 2006
- HRMY 2017
- Country
- KAR United States
- HRMY United States
- Employees
- KAR N/A
- HRMY N/A
- Industry
- KAR Retail-Auto Dealers and Gas Stations
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- KAR Consumer Discretionary
- HRMY Health Care
- Exchange
- KAR Nasdaq
- HRMY Nasdaq
- Market Cap
- KAR 1.9B
- HRMY 2.1B
- IPO Year
- KAR 2009
- HRMY 2020
- Fundamental
- Price
- KAR $19.86
- HRMY $33.22
- Analyst Decision
- KAR Buy
- HRMY Buy
- Analyst Count
- KAR 4
- HRMY 9
- Target Price
- KAR $20.25
- HRMY $47.00
- AVG Volume (30 Days)
- KAR 686.2K
- HRMY 1.3M
- Earning Date
- KAR 11-06-2024
- HRMY 10-29-2024
- Dividend Yield
- KAR N/A
- HRMY N/A
- EPS Growth
- KAR N/A
- HRMY N/A
- EPS
- KAR 0.19
- HRMY 2.11
- Revenue
- KAR $1,687,800,000.00
- HRMY $681,879,000.00
- Revenue This Year
- KAR $4.74
- HRMY $24.63
- Revenue Next Year
- KAR $4.64
- HRMY $18.04
- P/E Ratio
- KAR $108.14
- HRMY $15.77
- Revenue Growth
- KAR 3.76
- HRMY 25.83
- 52 Week Low
- KAR $12.86
- HRMY $26.03
- 52 Week High
- KAR $20.45
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- KAR 72.53
- HRMY 44.15
- Support Level
- KAR $15.83
- HRMY $32.37
- Resistance Level
- KAR $20.45
- HRMY $36.68
- Average True Range (ATR)
- KAR 0.58
- HRMY 2.02
- MACD
- KAR 0.34
- HRMY -0.07
- Stochastic Oscillator
- KAR 87.34
- HRMY 20.73
About KAR OPENLANE Inc.
Openlane Inc offers a digital marketplace for used vehicles. The services comprise financing, repossessions, repairs, transportation, warranty, and inventory services. It operates used-vehicle auctions and offers complete online services for all parties involved. The company has two operating segments which include Marketplace and Finance, of which it generates the majority of the revenue from the Marketplace segment.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.